Image For Activity Cover
Virtual Tumor Board: GI - April 2021
Activity Overview

In this tumor board, the participants will be able to:

  • Identify Peptide Recteptor Radionuclide Therapy (PRRT) as a treatment modality in neuroendocrine tumors
  • Identify necessary tumor characteristics and radiographic workup prior to use of PRRT
  • Recognize considerations for initiation of PRRT in the spectrum of other treatment modalities for neuroendocrine tumors
  • Learn side effect profile of PRRT
Moderating this session will be Thomas Clancy, MD, FACS, Brigham and Women’s Hospital/Dana-Farber Cancer Institute.

Julie Hallet, MD, MSc, FRCSC, Susan Leslie Neuroendocrine Tumors Clinic, Sunnybrook Health Sciences Centre
Alexandra Gangi, MD, Cedars Sinai Medical Center
Pamela Kunz, MD, Yale School of Medicine 
Thomas Hope, MD, University of California, San Francisco 
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Powered By